Kentucky Retirement Systems Insurance Trust Fund cut its position in shares of Teleflex Incorporated (NYSE:TFX – Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,395 shares of the medical technology company’s stock after selling 124 shares during the quarter. Kentucky Retirement Systems Insurance Trust Fund’s holdings in Teleflex were worth $345,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also recently bought and sold shares of TFX. Russell Investments Group Ltd. raised its holdings in Teleflex by 15.8% during the first quarter. Russell Investments Group Ltd. now owns 18,838 shares of the medical technology company’s stock worth $4,245,000 after purchasing an additional 2,570 shares during the last quarter. Mitsubishi UFJ Trust & Banking Corp raised its holdings in Teleflex by 5.7% during the first quarter. Mitsubishi UFJ Trust & Banking Corp now owns 26,140 shares of the medical technology company’s stock worth $5,912,000 after purchasing an additional 1,412 shares during the last quarter. Vanguard Group Inc. raised its holdings in Teleflex by 1.8% during the first quarter. Vanguard Group Inc. now owns 5,550,727 shares of the medical technology company’s stock worth $1,255,408,000 after purchasing an additional 96,711 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in Teleflex by 26.3% during the first quarter. O Shaughnessy Asset Management LLC now owns 2,313 shares of the medical technology company’s stock worth $523,000 after purchasing an additional 482 shares during the last quarter. Finally, UniSuper Management Pty Ltd raised its holdings in Teleflex by 573.8% during the first quarter. UniSuper Management Pty Ltd now owns 4,629 shares of the medical technology company’s stock worth $1,047,000 after purchasing an additional 3,942 shares during the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
TFX has been the subject of several research reports. StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a report on Wednesday. Truist Financial reissued a “hold” rating and set a $227.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Stephens raised their price target on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, August 2nd. Finally, Royal Bank of Canada dropped their price target on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Teleflex has a consensus rating of “Moderate Buy” and an average target price of $259.25.
Teleflex Price Performance
Shares of NYSE:TFX opened at $193.07 on Wednesday. The company has a market cap of $8.97 billion, a P/E ratio of 38.38, a P/E/G ratio of 1.97 and a beta of 1.18. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52 week low of $189.93 and a 52 week high of $257.85. The business has a fifty day simple moving average of $229.33 and a 200-day simple moving average of $223.34.
Teleflex (NYSE:TFX – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts’ consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same quarter in the previous year, the business earned $3.64 earnings per share. The business’s revenue for the quarter was up 2.4% on a year-over-year basis. Equities research analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current year.
Teleflex Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex’s payout ratio is currently 27.04%.
Teleflex Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
- Five stocks we like better than Teleflex
- What Is WallStreetBets and What Stocks Are They Targeting?
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- Canada Bond Market Holiday: How to Invest and Trade
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- Using the MarketBeat Stock Split Calculator
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.